Cairo-Mubasher: Kahira Pharmaceuticals targets a 17% increase in net earnings for the fiscal year 2016/2017, compared to forecasts for the current year.
The pharmaceutical producer targets EGP 48.33 million ($6.17 million) in net earnings, compared to forecasts of EGP 41.23 million ($5.26 million) in 2015/2016, according to a bourse statement.
The proposed investments in FY16/17 estimated budget total nearly EGP 22.2 million ($2.83 million).
Net profits before taxes amounted to EGP 38.1 million ($4.87 million) in 2015/2016, compared with EGP 35 million ($4.47 million) a year earlier.
